CTX 439
Alternative Names: CRD-1835439; CTX-439Latest Information Update: 12 Jul 2024
At a glance
- Originator Chordia Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action CDK13 protein inhibitors; Cyclin dependent kinase 12 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours